Aroa Biosurgery Limited
ASX:ARX.AX
Overview | Financials
Company Name | Aroa Biosurgery Limited |
Symbol | ARX.AX |
Currency | AUD |
Price | 0.49 |
Market Cap | 169,001,000 |
Dividend Yield | 0% |
52-week-range | 0.44 - 0.87 |
Industry | Medical Devices |
Sector | Healthcare |
CEO | Dr. Brian Ward |
Website | https://aroabio.com |
An error occurred while fetching data.
About Aroa Biosurgery Limited
Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and distributing medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. The company's products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD